NASDAQ:LMAT - LeMaitre Vascular Stock Price, Price Target & More

$30.75 -8.26 (-21.17 %)
(As of 04/26/2018 10:54 AM ET)
Previous Close$39.01
Today's Range$29.25 - $35.89
52-Week Range$25.05 - $41.28
Volume488,003 shs
Average Volume132,058 shs
Market Capitalization$748.83 million
P/E Ratio45.36
Dividend Yield0.72%

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular logoLeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and Reddick cholangiogram catheters to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Receive LMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments


Debt-to-Equity RatioN/A
Current Ratio6.09%
Quick Ratio4.50%


Trailing P/E Ratio45.36
Forward P/E Ratio31.38
P/E Growth2.65

Sales & Book Value

Annual Sales$100.87 million
Price / Sales5.88
Cash Flow$0.8733 per share
Price / Cash35.21
Book Value$5.70 per share
Price / Book5.39


EPS (Most Recent Fiscal Year)$0.86
Net Income$17.17 million
Net Margins17.03%
Return on Equity16.93%
Return on Assets14.74%


Outstanding Shares19,300,000

How to Become a New Pot Stock Millionaire

LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular declared a quarterly dividend on Friday, February 23rd. Investors of record on Thursday, March 22nd will be paid a dividend of $0.07 per share on Thursday, April 5th. This represents a $0.28 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend is Wednesday, March 21st. This is a boost from LeMaitre Vascular's previous quarterly dividend of $0.06. View LeMaitre Vascular's Dividend History.

How will LeMaitre Vascular's stock buyback program work?

LeMaitre Vascular declared that its Board of Directors has approved a stock repurchase plan on Friday, July 28th 2017, which allows the company to repurchase $7,500,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 1.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board believes its stock is undervalued.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) released its earnings results on Wednesday, April, 25th. The medical instruments supplier reported $0.19 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.21 by $0.02. The medical instruments supplier earned $25.99 million during the quarter, compared to analysts' expectations of $26.42 million. LeMaitre Vascular had a net margin of 17.03% and a return on equity of 16.93%. The business's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.16 earnings per share. View LeMaitre Vascular's Earnings History.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular issued an update on its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.05-1.13 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.98. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $111.05 million.LeMaitre Vascular also updated its Q2 guidance to $0.41-0.43 EPS.

What price target have analysts set for LMAT?

5 equities research analysts have issued 1-year price objectives for LeMaitre Vascular's stock. Their predictions range from $31.00 to $34.00. On average, they expect LeMaitre Vascular's stock price to reach $33.00 in the next year. View Analyst Ratings for LeMaitre Vascular.

Who are some of LeMaitre Vascular's key competitors?

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:
  • Mr. George W. LeMaitre, Chairman & CEO (Age 53)
  • Mr. David B. Roberts, Pres and Director (Age 54)
  • Mr. Joseph P. Pellegrino Jr., CFO, Treasurer, Sec. & Director (Age 53)
  • Dr. George D. LeMaitre M.D., FACS, Founder and Chairman of Scientific Advisory Board (Age 84)
  • Mr. Trent G. Kamke, Sr. VP of Operations (Age 47)

Has LeMaitre Vascular been receiving favorable news coverage?

News coverage about LMAT stock has been trending positive recently, Accern reports. The research firm scores the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LeMaitre Vascular earned a news sentiment score of 0.39 on Accern's scale. They also gave news coverage about the medical instruments supplier an impact score of 47.17 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of LeMaitre Vascular?

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LMAT stock can currently be purchased for approximately $30.75.

How big of a company is LeMaitre Vascular?

LeMaitre Vascular has a market capitalization of $748.83 million and generates $100.87 million in revenue each year. The medical instruments supplier earns $17.17 million in net income (profit) each year or $0.86 on an earnings per share basis. LeMaitre Vascular employs 423 workers across the globe.

How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.

MarketBeat Community Rating for LeMaitre Vascular (LMAT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  274 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  454
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe LMAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMAT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

LeMaitre Vascular (NASDAQ:LMAT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for LeMaitre Vascular in the last 12 months. Their average twelve-month price target is $33.00, suggesting that the stock has a possible upside of 7.32%. The high price target for LMAT is $34.00 and the low price target for LMAT is $31.00. There are currently 5 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $33.00$32.50$31.50$31.50
Price Target Upside: 7.32% upside9.19% downside0.77% upside0.77% upside

LeMaitre Vascular (NASDAQ:LMAT) Consensus Price Target History

Price Target History for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/26/2018Stifel NicolausDowngradeBuy -> Hold$40.00 -> $34.00HighView Rating Details
2/23/2018Canaccord GenuityReiterated RatingHold$33.00LowView Rating Details
10/27/2017BenchmarkDowngradeBuy -> HoldN/AView Rating Details
10/27/2017First AnalysisDowngradeOverweight -> Equal Weight$34.00N/AView Rating Details
6/6/2017Craig HallumInitiated CoverageHold$31.00LowView Rating Details
2/22/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50N/AView Rating Details
(Data available from 4/26/2016 forward)


LeMaitre Vascular (NASDAQ:LMAT) Earnings History and Estimates Chart

Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Earnings Estimates

2018 EPS Consensus Estimate: $0.94
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.20$0.20$0.20
Q2 20182$0.22$0.26$0.24
Q3 20182$0.21$0.25$0.23
Q4 20182$0.26$0.28$0.27

LeMaitre Vascular (NASDAQ LMAT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018Q1 2018$0.21$0.19$26.42 million$25.99 millionViewN/AView Earnings Details
2/21/2018Q4 2017$0.20$0.21$26.23 million$26.15 millionViewListenView Earnings Details
10/26/2017Q3 2017$0.20$0.25$25.49 million$24.80 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.17$0.23$25.42 million$25.80 millionViewN/AView Earnings Details
5/4/2017Q1 2017$0.1310$0.16$23.48 million$24.10 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.13$0.16$23.50 million$24.14 millionViewN/AView Earnings Details
2/21/2017Q4 2016$0.15$0.13$23.70 million$23.30 millionViewListenView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11$20.22 million$20.26 millionViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.0780$0.11$18.78 million$19.03 millionViewListenView Earnings Details
7/28/2015Q2$0.07$0.10$18.90 million$19.90 millionViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05$17.09 million$17.50 millionViewListenView Earnings Details
7/29/2014Q2 2014$0.05$0.09$17.57 million$18.16 millionViewN/AView Earnings Details
4/29/2014Q1 2014$0.02$0.02$16.99 million$16.75 millionViewN/AView Earnings Details
2/25/2014Q4$0.05$0.05$16.45 million$17.92 millionViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.04$0.06$15.42 million$15.95 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.01)$0.05$15.00 million$15.38 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.06$0.03ViewN/AView Earnings Details
10/30/2012Q3 2012$0.04$0.04ViewN/AView Earnings Details
7/31/2012Q2 2012$0.04$0.05ViewN/AView Earnings Details
5/2/2012Q1 2012$0.04$0.02ViewN/AView Earnings Details
2/27/2012Q4 2011$0.06$0.03ViewN/AView Earnings Details
10/27/2011Q3 2011$0.08$0.06ViewN/AView Earnings Details
7/28/2011Q2 2011$0.09$0.06ViewN/AView Earnings Details
4/28/2011Q1 2011$0.06$0.05ViewN/AView Earnings Details
2/28/2011Q4 2010$0.25ViewN/AView Earnings Details
10/28/2010Q3 2010$0.08$0.09ViewN/AView Earnings Details
7/28/2010Q2 2010$0.06$0.09ViewN/AView Earnings Details
4/29/2010Q1 2010$0.05$0.06ViewN/AView Earnings Details
3/4/2010Q4 2009$0.08ViewN/AView Earnings Details
10/28/2009Q3 2009$0.08ViewN/AView Earnings Details
7/29/2009Q2 2009$0.03$0.06ViewN/AView Earnings Details
4/28/2009Q1 2009($0.17)($0.04)ViewN/AView Earnings Details
3/3/2009Q4 2008$0.03ViewN/AView Earnings Details
10/29/2008Q3 2008($0.02)($0.01)ViewN/AView Earnings Details
7/29/2008Q2 2008($0.04)($0.04)ViewN/AView Earnings Details
4/30/2008Q1 2008($0.07)($0.12)ViewN/AView Earnings Details
3/4/2008Q4 2007($0.03)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


LeMaitre Vascular (NASDAQ:LMAT) Dividend Information

LeMaitre Vascular pays an annual dividend of $0.28 per share, with a dividend yield of 0.91%. LMAT's most recent quarterly dividend payment was Thursday, April 5. LeMaitre Vascular pays out 32.56% of its earnings out as a dividend.
Most Recent Dividend:4/5/2018
Annual Dividend:$0.28
Dividend Yield:0.91%
Payout Ratio:32.56% (Trailing 12 Months of Earnings)
28.57% (Based on This Year's Estimates)
25.00% (Based on Next Year's Estimates)
Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

LeMaitre Vascular (NASDAQ LMAT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 72.78%
Insider Trading History for LeMaitre Vascular (NASDAQ:LMAT)
Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ LMAT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2018George W LemaitreChairmanSell30,000$36.19$1,085,700.003,180,709View SEC Filing  
3/5/2018George W LemaitreChairmanSell45,000$34.66$1,559,700.003,225,709View SEC Filing  
3/2/2018George W LemaitreCEOSell15,000$34.55$518,250.003,225,709View SEC Filing  
2/28/2018George W LemaitreCEOSell5,700$35.56$202,692.003,259,263View SEC Filing  
2/26/2018George W LemaitreCEOSell42,036$35.68$1,499,844.483,259,263View SEC Filing  
11/6/2017David B RobertsInsiderSell4,123$32.14$132,513.2224,482View SEC Filing  
8/30/2017David B RobertsInsiderSell26,683$36.67$978,465.6148,108View SEC Filing  
8/30/2017George W LemaitreCEOSell15,000$37.13$556,950.003,325,508View SEC Filing  
8/29/2017George W LemaitreCEOSell15,000$36.72$550,800.003,325,508View SEC Filing  
8/28/2017George W LemaitreCEOSell30,000$36.43$1,092,900.003,325,508View SEC Filing  
8/25/2017George W LemaitreChairmanSell40,000$33.89$1,355,600.003,390,508View SEC Filing  
8/24/2017George W LemaitreCEOSell15,000$33.97$509,550.003,390,508View SEC Filing  
8/23/2017George W LemaitreCEOSell5,000$33.91$169,550.003,390,508View SEC Filing  
8/17/2017Lawrence J JasinskiDirectorSell2,030$34.23$69,486.908,333View SEC Filing  
8/11/2017George W LemaitreChairmanSell21,300$32.90$700,770.003,405,508View SEC Filing  
8/10/2017George W LemaitreCEOSell11,300$32.79$370,527.003,405,508View SEC Filing  
8/9/2017George W LemaitreChairmanSell30,000$33.65$1,009,500.003,436,808View SEC Filing  
8/8/2017George W LemaitreCEOSell10,000$34.02$340,200.003,436,808View SEC Filing  
8/7/2017George W LemaitreCEOSell10,000$33.62$336,200.003,436,808View SEC Filing  
8/7/2017Peter R GebauerInsiderSell6,224$33.85$210,682.408,477View SEC Filing  
8/4/2017David B RobertsInsiderSell48,317$33.12$1,600,259.0430,105View SEC Filing  
8/3/2017George W LemaitreChairmanSell58,700$33.97$1,994,039.003,471,808View SEC Filing  
8/3/2017Peter R GebauerInsiderSell22,067$34.28$756,456.764,486View SEC Filing  
8/1/2017Lawrence J JasinskiDirectorSell6,500$34.47$224,055.0012,863View SEC Filing  
6/1/2017Michael T WijasVPSell2,346$31.42$73,711.323,584View SEC Filing  
5/24/2017Trent G KamkeInsiderSell15,780$30.28$477,818.4031,341View SEC Filing  
5/18/2017George W LemaitreChairmanSell21,225$30.11$639,084.753,386,295View SEC Filing  
5/11/2017David B RobertsInsiderSell39,531$30.37$1,200,556.477,414View SEC Filing  
5/10/2017George W LemaitreChairmanSell63,622$30.98$1,971,009.563,450,815View SEC Filing  
5/9/2017George W LemaitreCEOSell34,517$30.67$1,058,636.393,450,815View SEC Filing  
5/8/2017George W LemaitreCEOSell9,102$31.12$283,254.243,450,815View SEC Filing  
5/4/2017David B RobertsInsiderSell44,340$31.14$1,380,747.6046,945View SEC Filing  
5/3/2017George W LemaitreChairmanSell87,342$32.35$2,825,513.703,484,149View SEC Filing  
3/10/2017David B RobertsInsiderSell5,900$22.44$132,396.0046,945View SEC Filing  
3/1/2017George W LemaitreChairmanSell10,000$22.36$223,600.003,451,694View SEC Filing  
2/28/2017George W LemaitreCEOSell3,000$22.27$66,810.003,451,694View SEC Filing  
2/27/2017George W LemaitreCEOSell5,000$22.31$111,550.003,451,694View SEC Filing  
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.6069,793View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.6879,793View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.003,395,063View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00119,793View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.103,443,098View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.2031,283View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.7031,283View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00134,793View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.003,491,564View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.523,491,564View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.533,491,564View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00188,858View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00188,858View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00188,858View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.883,512,839View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.603,516,387View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.0012,863View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00140,493View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.003,516,387View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.0025,374View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.893,521,849View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.003,521,849View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.003,521,849View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.6053,339View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.7612,787View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.0015,573View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.8015,642View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.0018,183View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.3012,204View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.123,522,749View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.0020,492View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.603,522,749View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.953,522,749View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.133,549,133View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96162,434View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.7022,692View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60147,136View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56107,605View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90125,049View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95127,739View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20140,606View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93168,096View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48110,389View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.4870,420View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.3270,420View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00170,839View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35182,595View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.763,633,333View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80110,389View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.0170,420View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00180,839View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.0070,420View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.003,698,385View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.0014,113View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.203,728,385View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.803,728,385View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.003,728,385View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.503,786,229View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.5570,420View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.3170,420View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.673,802,419View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.643,846,869View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.8570,420View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.003,888,369View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.3470,420View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00190,839View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.2870,420View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00206,710View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50174,581View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.0416,141View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05174,581View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00174,581View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)


LeMaitre Vascular (NASDAQ LMAT) News Headlines

Stifel Nicolaus Downgrades LeMaitre Vascular (LMAT) to HoldStifel Nicolaus Downgrades LeMaitre Vascular (LMAT) to Hold - April 26 at 9:48 AM
LeMaitre Vascular misses by $0.02, misses on revenueLeMaitre Vascular misses by $0.02, misses on revenue - April 26 at 9:16 AM
LeMaitre Vasculars (LMAT) CEO George LeMaitre on Q1 2018 Results - Earnings Call TranscriptLeMaitre Vascular's (LMAT) CEO George LeMaitre on Q1 2018 Results - Earnings Call Transcript - April 26 at 9:16 AM
LeMaitre: 1Q Earnings SnapshotLeMaitre: 1Q Earnings Snapshot - April 26 at 9:16 AM
LeMaitre Vascular (LMAT) Issues Q2 Earnings GuidanceLeMaitre Vascular (LMAT) Issues Q2 Earnings Guidance - April 25 at 6:10 PM
LeMaitre Vascular (LMAT) Issues FY18 Earnings GuidanceLeMaitre Vascular (LMAT) Issues FY18 Earnings Guidance - April 25 at 6:10 PM
LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) - April 25 at 4:37 PM
LeMaitre Vascular, Inc. (LMAT) Expected to Post Quarterly Sales of $26.41 MillionLeMaitre Vascular, Inc. (LMAT) Expected to Post Quarterly Sales of $26.41 Million - April 25 at 2:30 AM
LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out? - April 24 at 4:41 PM
LeMaitre Vascular (LMAT) Scheduled to Post Earnings on WednesdayLeMaitre Vascular (LMAT) Scheduled to Post Earnings on Wednesday - April 23 at 8:16 PM
LeMaitre Vascular, Inc. (LMAT) Expected to Post Earnings of $0.20 Per ShareLeMaitre Vascular, Inc. (LMAT) Expected to Post Earnings of $0.20 Per Share - April 23 at 7:14 PM
LeMaitre Vascular (LMAT) Stock Rating Lowered by Zacks Investment ResearchLeMaitre Vascular (LMAT) Stock Rating Lowered by Zacks Investment Research - April 20 at 10:45 AM
LeMaitre Vascular Inc (LMAT) Receives Average Rating of "Buy" from BrokeragesLeMaitre Vascular Inc (LMAT) Receives Average Rating of "Buy" from Brokerages - April 20 at 1:43 AM
LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018 - April 18 at 4:43 PM
LeMaitre Vascular (LMAT) Cut to "Buy" at BidaskClubLeMaitre Vascular (LMAT) Cut to "Buy" at BidaskClub - April 16 at 9:16 AM
LeMaitre Vascular (LMAT) Raised to "Buy" at Zacks Investment ResearchLeMaitre Vascular (LMAT) Raised to "Buy" at Zacks Investment Research - April 14 at 8:01 PM
LeMaitre Vascular, Inc. (LMAT) Sees Hammer Chart Pattern: Time to Buy?LeMaitre Vascular, Inc. (LMAT) Sees Hammer Chart Pattern: Time to Buy? - April 11 at 10:07 AM
LeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.41 MillionLeMaitre Vascular Inc (LMAT) Expected to Post Quarterly Sales of $26.41 Million - April 8 at 2:10 AM
Zacks: Brokerages Expect LeMaitre Vascular Inc (LMAT) to Announce $0.20 Earnings Per ShareZacks: Brokerages Expect LeMaitre Vascular Inc (LMAT) to Announce $0.20 Earnings Per Share - April 6 at 7:16 PM
Lemaitre Vascular (LMAT) Sells General Surgery Product Lines for $7.4MLemaitre Vascular (LMAT) Sells General Surgery Product Lines for $7.4M - April 6 at 9:55 AM
LeMaitre Vascular Divests General Surgery Product LinesLeMaitre Vascular Divests General Surgery Product Lines - April 6 at 9:55 AM
LeMaitre Vascular (LMAT) Rating Increased to Buy at ValuEngineLeMaitre Vascular (LMAT) Rating Increased to Buy at ValuEngine - April 5 at 1:11 PM
Head-To-Head Survey: Cryolife (CRY) vs. LeMaitre Vascular (LMAT)Head-To-Head Survey: Cryolife (CRY) vs. LeMaitre Vascular (LMAT) - April 5 at 3:23 AM
LeMaitre Vascular (LMAT) Raised to Buy at Zacks Investment ResearchLeMaitre Vascular (LMAT) Raised to Buy at Zacks Investment Research - April 3 at 10:58 PM
BidaskClub Upgrades LeMaitre Vascular (LMAT) to Strong-BuyBidaskClub Upgrades LeMaitre Vascular (LMAT) to Strong-Buy - April 3 at 11:00 AM
LeMaitre Vascular (LMAT) Lowered to "Hold" at Zacks Investment ResearchLeMaitre Vascular (LMAT) Lowered to "Hold" at Zacks Investment Research - March 31 at 4:56 PM
Zacks Investment Research Downgrades LeMaitre Vascular (LMAT) to HoldZacks Investment Research Downgrades LeMaitre Vascular (LMAT) to Hold - March 30 at 11:10 PM
LeMaitre Vascular (LMAT) Raised to "Sell" at BidaskClubLeMaitre Vascular (LMAT) Raised to "Sell" at BidaskClub - March 28 at 12:34 AM
LeMaitre Vascular Inc (LMAT) Given Consensus Rating of "Hold" by BrokeragesLeMaitre Vascular Inc (LMAT) Given Consensus Rating of "Hold" by Brokerages - March 26 at 1:34 AM
LeMaitre Vascular (LMAT) Stock Rating Upgraded by BidaskClubLeMaitre Vascular (LMAT) Stock Rating Upgraded by BidaskClub - March 25 at 9:49 AM
Zacks Investment Research Upgrades LeMaitre Vascular (LMAT) to "Buy"Zacks Investment Research Upgrades LeMaitre Vascular (LMAT) to "Buy" - March 24 at 7:20 PM
LeMaitre Vascular (LMAT) Cut to "Hold" at BidaskClubLeMaitre Vascular (LMAT) Cut to "Hold" at BidaskClub - March 24 at 4:30 PM
LeMaitre Vascular Inc (LMAT) Expected to Post Earnings of $0.20 Per ShareLeMaitre Vascular Inc (LMAT) Expected to Post Earnings of $0.20 Per Share - March 20 at 9:08 PM
Edited Transcript of LMAT earnings conference call or presentation 21-Feb-18 10:00pm GMTEdited Transcript of LMAT earnings conference call or presentation 21-Feb-18 10:00pm GMT - March 20 at 4:20 PM
LeMaitre Vascular Inc Forecasted to Earn Q4 2018 Earnings of $0.28 Per Share (LMAT)LeMaitre Vascular Inc Forecasted to Earn Q4 2018 Earnings of $0.28 Per Share (LMAT) - March 12 at 6:34 AM
LeMaitre Vascular (LMAT) Upgraded at BidaskClubLeMaitre Vascular (LMAT) Upgraded at BidaskClub - March 10 at 5:28 PM
Insider Selling: LeMaitre Vascular Inc (LMAT) Chairman Sells 30,000 Shares of StockInsider Selling: LeMaitre Vascular Inc (LMAT) Chairman Sells 30,000 Shares of Stock - March 8 at 6:29 PM
LeMaitre Vascular Inc (LMAT) Shares Sold by Ranger Investment Management L.P.LeMaitre Vascular Inc (LMAT) Shares Sold by Ranger Investment Management L.P. - March 6 at 2:11 PM
LeMaitre Vascular Inc (LMAT) Shares Sold by AWM Investment Company Inc.LeMaitre Vascular Inc (LMAT) Shares Sold by AWM Investment Company Inc. - March 6 at 4:44 AM
Insider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 15,000 Shares of StockInsider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 15,000 Shares of Stock - March 5 at 9:30 PM
LeMaitre Vascular Inc (LMAT) Chairman Sells $1,559,700.00 in StockLeMaitre Vascular Inc (LMAT) Chairman Sells $1,559,700.00 in Stock - March 5 at 9:11 PM
Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Quarterly Sales of $26.41 MillionZacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Quarterly Sales of $26.41 Million - March 5 at 3:44 AM
Zacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Earnings of $0.20 Per ShareZacks: Analysts Expect LeMaitre Vascular Inc (LMAT) Will Post Earnings of $0.20 Per Share - March 3 at 5:24 PM
LeMaitre Vascular Inc (LMAT) Given Average Recommendation of "Hold" by AnalystsLeMaitre Vascular Inc (LMAT) Given Average Recommendation of "Hold" by Analysts - March 1 at 1:26 AM
LeMaitre Vascular Inc (LMAT) CEO Sells $202,692.00 in StockLeMaitre Vascular Inc (LMAT) CEO Sells $202,692.00 in Stock - March 1 at 12:38 AM
Insider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 42,036 Shares of StockInsider Selling: LeMaitre Vascular Inc (LMAT) CEO Sells 42,036 Shares of Stock - March 1 at 12:20 AM
LeMaitre Vascular to Present at Upcoming Investor ConferencesLeMaitre Vascular to Present at Upcoming Investor Conferences - February 28 at 9:25 AM
Comerica Bank Raises Holdings in LeMaitre Vascular Inc (LMAT)Comerica Bank Raises Holdings in LeMaitre Vascular Inc (LMAT) - February 27 at 6:00 AM
Q1 2018 EPS Estimates for LeMaitre Vascular Inc Lifted by Barrington Research (LMAT)Q1 2018 EPS Estimates for LeMaitre Vascular Inc Lifted by Barrington Research (LMAT) - February 26 at 2:26 AM
LeMaitre Vasculars (LMAT) "Hold" Rating Reaffirmed at Canaccord GenuityLeMaitre Vascular's (LMAT) "Hold" Rating Reaffirmed at Canaccord Genuity - February 24 at 7:10 AM

SEC Filings

LeMaitre Vascular (NASDAQ:LMAT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


LeMaitre Vascular (NASDAQ:LMAT) Income Statement, Balance Sheet and Cash Flow Statement


LeMaitre Vascular (NASDAQ LMAT) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.